Filing Details

Accession Number:
0001231977-10-000058
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-07-19 13:00:00
Reporting Period:
2010-07-16
Filing Date:
2010-07-19
Accepted Time:
2010-07-19 16:12:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899866 Alexion Pharmaceuticals Inc ALXN Pharmaceutical Preparations (2834) 133648318
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1457477 David Hallal C/O Alexion Pharmaceuticals, Inc
352 Knotter Drive
Cheshire CT 06410
Svp Commercial Ops, Americas No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $.0001 Per Share Disposition 2010-07-16 227 $51.08 6,389 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. These sales were made to cover the withholding taxes immediately following the vesting of previously granted Restricted Stock.